G Medical Innovations Holdings Ltd (GMVDF) Research

G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an intuitive medical device for measuring vital signs, which also incorporates electronic medical record functionality and adheres to clinical-grade reporting standards. Another offering is the Extended Holter Patch System, a multi-channel biosensor worn by patients that continuously records ECG data for up to two weeks. The company is also in the process of developing a Wireless Vital Signs Monitoring System, aiming to provide uninterrupted, real-time tracking of physiological parameters and biometrics. Furthermore, G Medical Innovations offers comprehensive monitoring services, encompassing both support for independent diagnostic testing facilities and personalized private monitoring solutions. Established in 2014, the company's corporate headquarters are located in Rehovot, Israel.

Market snapshot

Symbol
GMVDF
Price
$0.00
Day change
0.00%
Market cap
$1.8M
P/E ratio
-0.10x
52-week range
0.00001-0.0251
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Next earnings
in 2 months

Peer companies

  • Acura Pharmaceuticals, Inc. (ACUR)
  • Amazonas Florestal, Ltd (AZFL)
  • Curative Biosciences, Inc. (CBDX)
  • ECGI Holdings, Inc. (ECGI)
  • Filament Health Corp. (FLHLF)
  • GeneLink, Inc. (GNLKQ)
  • Integrative Health Technologies, Inc. (IHTI)
  • Kali, Inc. (KALY)

Open G Medical Innovations Holdings Ltd (GMVDF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.